Wednesday, 14 April 2021

SRAM & MRAM Group injects Rs 100 Cr to manufacture PPE in India

07 April 2021 | News

The group has plans to set up another 40 factories within the next 6 months across the globe to help build a viable PPE market

Image credit- shutterstock.com

Image credit- shutterstock.com

SRAM & MRAM Group, a UK-based conglomerate that has been instrumental in contributing to the society and adding its bit to help fight the pandemic, is investing Rs 100 Crores in the Indian market.

In its endeavor to help the world for upgrading safety measures, the company has planned to invest in manufacturing the PPE products under its flagship brand ‘Walletz4u’.

The company is set to produce premium Nitrile Examination Gloves that are currently being produced from its factories in Malaysia, Thailand and Vietnam.

With the series of investments and manufacturing units in place, the company is gearing up to become the leading original equipment manufacturers of Medical and Industrial grade gloves in East Asia.

Under the 'Walletz4u' flagship, a brand owned by SRAM & MRAM Group, one of the world’s leading public health emergency management solutions companies, the brand is the leader in manufacturing their flagship ‘Medical Protection Supply’ products for consumers all across the globe.

Speaking on the development, Dr. Sailesh Lachu Hiranandani, Chairman, SRAM & MRAM Group, said, “SRAM has geared itself to tackle the problem of PPE Shortage in the world by acquiring and leasing a whole lot of production lines to meet the ever increasing demand especially gloves of all types for all industry verticals.”

Today looking at the current scenario, there is an unprecedented demand for protective gears like Sanitizers, Gloves, Face Shields, etc. And in order to cater to the same, SRAM & MRAM has been on a spree to set-up more than 12 factories all across Malaysia, Vietnam and India to produce these products under ‘Walletz4u’ branding. Furthermore, the group has plans to set up another 40 factories within the next 6 months across the globe to help build a viable PPE market.  

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account






Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls